| Literature DB >> 27618080 |
Ye Li1, Meihong Xu2, Rui Fan3, Xiaotao Ma4, Jiaojiao Gu5, Xiaxia Cai6, Rui Liu7, Qihe Chen8, Jinwei Ren9, Ruixue Mao10, Lei Bao11, Zhaofeng Zhang12, Junbo Wang13, Yong Li14.
Abstract
OBJECTIVE: Many patients with type 2 diabetes find it difficult to maintain good glycemic control. Undesirable glycemic control occurs greatly due to deficiencies of nutritional knowledge and difficulty in obtaining dietary prescriptions. The late middle-aged and elder individuals are the main populations that are affected by type 2 diabetes. The main purpose of this study was to investigate whether intensive nutrition education would make benefits for late middle-aged patients with type 2 diabetes.Entities:
Keywords: diabetes mellitus; education; late middle-aged adults; nutrition; type 2
Mesh:
Substances:
Year: 2016 PMID: 27618080 PMCID: PMC5036730 DOI: 10.3390/ijerph13090897
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow of participants though trial.
Contents of the diabetes nutrition education.
| Contents | |
|---|---|
| Knowledge of diabetes | Diagnosis of type 2 diabetes mellitus |
| Symptoms of type 2 diabetes mellitus | |
| Main causes of type 2 diabetes mellitus | |
| Complications of type 2 diabetes mellitus | |
| Diabetes medication | The importance of taking medications |
| Different types of diabetic medications | |
| The proper methods of taking diabetic medication | |
| Blood glucose monitoring | The importance of regular blood glucose monitoring |
| The optimal target range for blood glucose control | |
| Methods of self-monitoring of blood glucose | |
| Techniques of handling abnormal blood glucose | |
| Healthy diet | Balanced diet for type 2 diabetics |
| Appropriate caloric intake for type 2 diabetics | |
| Diet combination and cooking method for type 2 diabetics | |
| The importance of eating vegetables, fruits and whole grains | |
| Healthy lifestyle | The importance of regular exercise for type 2 diabetics |
| The appropriate exercise for type 2 diabetics | |
| Taking suitable exercises according to personal fitness level | |
| Giving up bad habits and maintaining healthy behaviors |
Baseline characteristics of the study participants according to group.
| Characteristic | Intervention Assignment | ||
|---|---|---|---|
| UNE ( | INE ( | ||
| Male | 52 (53.1) | 47 (48.0) | 0.48 |
| Age (years) | 58.3 (4.1) | 59.1 (4.6) | 0.23 |
| Duration of diabetes (years) | 6.5 (5.4) | 6.8 (4.8) | 0.63 |
| Diabetes medication use | |||
| No diabetes medication | 16 (16.3) | 14 (14.3) | 0.96 |
| Oral medication only | 48 (49.0) | 49 (50.0) | |
| Insulin only | 17 (17.3) | 16 (16.3) | |
| Oral medication and insulin | 17 (17.3) | 19 (19.4) | |
| Education | |||
| Illiteracy | 7 (7.1) | 2 (2.0) | 0.24 |
| Primary school | 9 (9.2) | 9 (9.2) | |
| Middle school | 25 (25.5) | 31 (31.6) | |
| High school | 29 (29.6) | 36 (36.7) | |
| College | 28 (28.6) | 20 (20.4) | |
| Height (cm) | 164.5 (7.1) | 163.9 (8.1) | 0.56 |
| Weight (kg) | 68.3 (10.0) | 69.1 (11.5) | 0.64 |
| BMI (kg/m2) | 25.1 (1.8) | 25.7 (3.7) | 0.26 |
Abbreviation: BMI: body mass index. Variables are reported as mean (standard deviation) or number (percent).
Diabetes knowledge, behavioral, and medication outcomes.
| Variable | UNE ( | INE ( | |||
|---|---|---|---|---|---|
| Baseline | 30-Day | Baseline | 30-Day | ||
| Diabetes Knowledge Questionnaire, mean(SD) | |||||
| Total score | 53.6 (18.2) | 61.8 (19.5) | 56.4 (16.4) | 84.5 (12.8) | <0.001 |
| Daily dietary intake | |||||
| Energy intake (kcal) | 2486 (307) | 2458 (396) | 2452 (253) | 2112 (274) | <0.001 |
| Protein(% of energy intake) | 19% | 19% | 17% | 18% | 0.043 |
| Carbohydrate (% of energy intake) | 43% | 44% | 46% | 60% | |
| Fat (% of energy intake) | 38% | 37% | 37% | 22% | |
| Fiber (g) | 19 (6) | 22 (5) | 21 (4) | 31 (6) | <0.001 |
| Exercise | |||||
| MVPA (min per day) | 23.3 (20.4) | 23.6 (18.2) | 26.7 (21.3) | 46.8 (14.6) | <0.001 |
| Sedentary time (hours per day) | 5.6 (2.4) | 6.1 (4.4) | 5.8 (3.2) | 4.5 (3.8) | 0.007 |
| 30-min MVPA per day, no. (% patients) | 31 (31.6) | 37 (37.8) | 28 (28.6) | 58 (59.2) | 0.003 |
| Glucose-lowering treatment, no. (% patients) | |||||
| Decrease | 2 (2.1) | 5 (5.1) | 0.199 | ||
| Increase | 9 (9.1) | 4 (4.1) | |||
| No change | 87 (88.8) | 89 (90.8) | |||
Abbreviation: MVPA: moderate to vigorous physical activity; * p-values are for the difference between the groups at the end of the study.
Figure 2Fingertip blood glucose of INE group. Abbreviations: FPG: fasting plasma glucose; PG: 2-h postprandial plasma glucose.
Means of baseline, 30-day changes in variables of participants according to group.
| Measure | UNE ( | INE ( | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | 30-Day | Change | Baseline | 30-Day | Change | ||||
| Weight (kg) | 68.3 (10.0) | 68.2 (10.2) | −0.1 (1.0) | 0.226 | 69.1 (11.5) | 68.3 (10.6) | −0.8 (2.9) | 0.012 | 0.625 |
| BMI (kg/m2) | 25.1 (1.8) | 25.0 (1.9) | −0.1 (0.4) | 0.169 | 25.7 (3.7) | 25.3 (3.4) | −0.3 (1.1) | 0.020 | 0.631 |
| FPG (mmol/L) | 9.3 (0.5) | 9.2 (0.5) | −0.0 (0.2) | 0.673 | 9.4 (3.1) | 8.3 (2.8) | −1.1 (2.4) | <0.001 | <0.001 |
| PG (mmol/L) | 18.5 (2.4) | 18.1 (2.3) | −0.4 (0.9) | <0.001 | 17.9 (5.6) | 15.6 (4.7) | −2.3 (3.9) | <0.001 | <0.001 |
| HbA1c (%) | 7.9 (0.4) | 8.0 (0.5) | 0.1 (0.4) | 0.224 | 7.9 (0.4) | 7.3 (0.9) | −0.6 (0.9) | <0.001 | <0.001 |
| TG (mmol/L) | 1.6 (0.5) | 1.6 (0.6) | 0.02 (0.2) | 0.305 | 1.8 (0.9) | 1.6 (0.9) | −0.2 (0.9) | 0.008 | 0.252 |
| TC (mmol/L) | 5.3 (1.1) | 5.2 (1.1) | −0.1 (0.2) | <0.001 | 5.1 (0.9) | 5.0 (1.0) | −0.1 (0.6) | 0.013 | 0.330 |
| HDL-c (mmol/L) | 1.3 (0.3) | 1.3 (0.2) | −0.1 (0.1) | <0.001 | 1.3 (0.2) | 1.3 (0.3) | 0.1 (0.1) | <0.001 | 0.616 |
| LDL-c (mmol/L) | 2.9 (0.5) | 2.9 (0.5) | 0.0 (0.1) | 0.986 | 3.0 (0.7) | 3.0 (0.8) | 0.0 (0.7) | 0.935 | 0.870 |
Abbreviations: BMI: body mass index; FPG: fasting plasma glucose; PG: 2-h postprandial plasma glucose; HbA1c: glycosylated hemoglobin; TG: triglycerides; TC: total cholesterol; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol. † p-values within the study group change, based on paired-sample t-tests or related samples Wilkoxon Ranks test. ‡ p-values between groups at the end of study period based on two samples t-test or two-sample Mann–Whitney U-test.